Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Inclusion Body Myopathy 2”

25 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 25 results

Not applicableStudy completedNCT02196909
What this trial is testing

Clinical, Biological and NMR Outcome Measures Study for Hereditary Inclusion Body Myopathy Due to Mutation of UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine Kinase Gene (GNE)

Who this might be right for
HIBM
Institut de Myologie, France 20
Testing effectiveness (Phase 2)Study completedNCT02346461
What this trial is testing

An Open Label Phase 2 Study of ManNAc in Subjects With GNE Myopathy

Who this might be right for
GNE Myopathy
National Human Genome Research Institute (NHGRI) 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT04231266
What this trial is testing

Multi-Center Study of ManNAc for GNE Myopathy

Who this might be right for
GNE Myopathy
Leadiant Biosciences, Inc. 54
Not applicableStudy completedNCT03760757
What this trial is testing

Effectiveness of Two Different Forms of Marine Oil on Indirect Markers of Muscle Damage and Soreness in Untrained Men

Who this might be right for
Inflammation; Muscle
Indiana University 57
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07511556
What this trial is testing

First-in-human Study of UX016 in GNEM

Who this might be right for
GNE Myopathy
Ultragenyx Pharmaceutical Inc 24
Testing effectiveness (Phase 2)Study completedNCT01830972
What this trial is testing

An Open Label Phase 2 Extension Study of Higher Dose Sialic Acid-Extended Release (SA-ER) Tablets and Sialic Acid-Immediate Release (SA-IR) Capsules in Patients With Glucosamine (UDP-N-acetyl)-2-Epimerase (GNE) Myopathy

Who this might be right for
GNE MyopathyHereditary Inclusion Body Myopathy (HIBM)
Ultragenyx Pharmaceutical Inc 59
Not applicableStudy completedNCT01784679
What this trial is testing

GNE-Myopathy Disease Monitoring Program (GNEM-DMP): A Registry and Prospective Observational Natural History Study to Assess GNE Myopathy or Hereditary Inclusion Body Myopathy (HIBM)

Who this might be right for
Hereditary Inclusion Body MyopathyGNE MyopathyNonaka Disease+2 more
Ultragenyx Pharmaceutical Inc 319
Large-scale testing (Phase 3)Study completedNCT02377921
What this trial is testing

Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Sialic Acid in Patients With Glucosamine (UDP-N-acetyl)-2-epimerase Myopathy (GNEM) or Hereditary Inclusion Body Myopathy (HIBM)

Who this might be right for
Hereditary Inclusion Body MyopathyDistal Myopathy With Rimmed VacuolesDistal Myopathy, Nonaka Type+1 more
Ultragenyx Pharmaceutical Inc 89
Not applicableStudy completedNCT01417533
What this trial is testing

A Natural History Study of Patients With GNE Myopathy and GNE-Related Diseases

Who this might be right for
GNE MyopathyGNE Related Diseases
National Human Genome Research Institute (NHGRI) 78
Not applicableUnknownNCT04009226
What this trial is testing

International GNE Myopathy Patient Registry

Who this might be right for
GNE MyopathyHereditary Inclusion Body Myopathy
Newcastle University 430
Not applicableStudy completedNCT01902940
What this trial is testing

Natural History in CCFDN and IBM Syndromes

Who this might be right for
Inclusion Body Myositis, SporadicInclusion Body Myopathy, Autosomal-recessiveInclusion Body Myopathy, Autosomal-dominant+1 more
Ludwig-Maximilians - University of Munich 350
Testing effectiveness (Phase 2)WithdrawnNCT03710941
What this trial is testing

Safety and Efficacy of REGN2477+REGN1033 in Patients With Sporadic Inclusion Body Myositis

Who this might be right for
Sporadic Inclusion Body Myositis
Regeneron Pharmaceuticals
Not applicableEnrolling By InvitationNCT07072676
What this trial is testing

The Use of Assistive Gait Devices Can Reduce the Risk of Falls in Patients With Neuromuscular Diseases Following a Training Period.

Who this might be right for
Inclusion Body MyositisMyotonic Dystrophy 1Myotonic Dystrophy 2+10 more
LMU Klinikum 30
Early research (Phase 1)Study completedNCT01359319
What this trial is testing

Safety and Pharmacokinetics of Sialic Acid Tables in Patients With Hereditary Inclusion Body Myopathy (HIBM)

Who this might be right for
Hereditary Inclusion Body Myopathy (HIBM)
Ultragenyx Pharmaceutical Inc 26
Testing effectiveness (Phase 2)Ended earlyNCT02731690
What this trial is testing

Evaluate the Safety of Aceneuramic Acid Extended Release (Ace-ER; UX001) Tablets in Glucosamine (UDP-N-acetyl)-2-Epimerase (GNE) Myopathy (GNEM) (Also Known as Hereditary Inclusion Body Myopathy [HIBM]) Patients With Severe Ambulatory Impairment

Who this might be right for
Hereditary Inclusion Body MyopathyDistal Myopathy With Rimmed VacuolesDistal Myopathy, Nonaka Type+3 more
Ultragenyx Pharmaceutical Inc 42
Large-scale testing (Phase 3)Study completedNCT01925209
What this trial is testing

Efficacy and Safety of Bimagrumab/BYM338 at 52 Weeks on Physical Function, Muscle Strength, Mobility in sIBM Patients

Who this might be right for
Sporadic Inclusion Body Myositis
Novartis Pharmaceuticals 251
Early research (Phase 1)Study completedNCT00195637
What this trial is testing

Intravenous Immune Globulin to Treat Hereditary Inclusion Body Myopathy

Who this might be right for
Hereditary Inclusion Body Myopathy
National Human Genome Research Institute (NHGRI) 4
Early research (Phase 1)Study completedNCT01634750
What this trial is testing

Phase I Clinical Trial of ManNAc in Patients With GNE Myopathy or Hereditary Inclusion Body Myopathy (HIBM)

Who this might be right for
Hereditary Inclusion Body Myopathy (HIBM)GNE Myopathy
National Human Genome Research Institute (NHGRI) 26
Not applicableStudy completedNCT04907162
What this trial is testing

Musculoskeletal Nociceptive Pain in Participants With Neuromuscular Disorders

Who this might be right for
Pompe Disease (Late-onset)Myotonic Dystrophy Type 1 (DM1)Myotonic Dystrophy Type 2+4 more
LMU Klinikum 82
Not applicableStudy completedNCT03348267
What this trial is testing

Protein Supplementation and Muscle Recovery in Football

Who this might be right for
Skeletal Muscle DamageMuscle InflammationMuscle Recovery+1 more
University of Thessaly 20
Load More Results